We came across a bearish thesis on DexCom, Inc. on Hunterbrook’s Substack. In this article, we will summarize the bulls’ thesis on DXCM. DexCom, Inc.’s share was trading at $65.41 as of October 15th. DXCM’s trailing and forward P/E were 46.79 and 25.64 respectively according to Yahoo Finance.
Hunterbrook Media’s investigation reveals severe safety, operational, and financial concerns at Dexcom (DXCM), particularly surrounding its G7 continuous glucose monitor (CGM). After...
